microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Hamam, Rimi ^a   Ali, Arwa M ^b,c   Alsaleh, Khalid A ^b   Kassem, Moustapha ^a,d   Alfayez, Musaed ^a   Aldahmash, Abdullah ^a,b   Alajez, Nehad M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c ASSIUT UNIVERSITY   (Egypt)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULATING MICRORNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; BREAST TUMOR; CANCER STAGING; CARCINOGENESIS; COHORT ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MIDDLE AGED; PATHOLOGY; UPREGULATION;

ADULT; AGED; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CARCINOGENESIS; CIRCULATING MICRORNA; COHORT STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RECEPTOR, ERBB-2; UP-REGULATION;

EID: 84968912748     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep25997     Document Type: Article

References (26)

1. Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics. CA: a cancer journal for clinicians 64, 9-29, doi: 10.3322/caac.21208 (2014).
2. El Bcheraoui, C. et al. Breast cancer screening in saudi arabia: free but almost no takers. Plos one 10, e0119051, doi: 10.1371/journal.pone.0119051 (2015).
3. He, L. & Hannon, G. J. MicroRNAs: small RNAs with a big role in gene regulation. Nature reviews. Genetics 5, 522-531, doi: 10.1038/nrg1379 (2004).
4. Alajez, N. M. et al. Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell death & disease 1, e85, doi: 10.1038/cddis.2010.64 (2010).
5. Hamam, D. et al. microRNA-320/RUNX2 axis regulates adipocytic differentiation of human mesenchymal (skeletal) stem cells. Cell death & disease 5, e1499, doi: 10.1038/cddis.2014.462 (2014).
6. Vishnubalaji, R. et al. Genome-wide mRNA and miRNA expression profiling reveal multiple regulatory networks in colorectal cancer. Cell death & disease 6, e1614, doi: 10.1038/cddis.2014.556 (2015).
7. Iorio, M. V. et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65, 7065-7070, doi: 10.1158/0008-5472.can-05-1783 (2005).
8. Mattie, M. D. et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 5, 24, doi: 10.1186/1476-4598-5-24 (2006).
9. Heneghan, H. M., Miller, N., Kelly, R., Newell, J. & Kerin, M. J. Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist 15, 673-682, doi: 10.1634/theoncologist.2010-0103 (2010).
10. Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America 105, 10513-10518, doi: 10.1073/pnas.0804549105 (2008).
11. Shin, V. Y., Siu, J. M., Cheuk, I., Ng, E. K. & Kwong, A. Circulating cell-free miRNAs as biomarker for triple-negative breast cancer. British journal of cancer 112, 1751-1759, doi: 10.1038/bjc.2015.143 (2015).
12. Stuckrath, I. et al. Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients. Oncotarget 6, 13387-13401 (2015).
13. Anker, P., Mulcahy, H., Chen, X. Q. & Stroun, M. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer metastasis reviews 18, 65-73 (1999).
14. Petricoin, E. F., 3rd et al. Serum proteomic patterns for detection of prostate cancer. Journal of the National Cancer Institute 94, 1576-1578 (2002).
15. Wang, G. K. et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. European heart journal 31, 659-666, doi: 10.1093/eurheartj/ehq013 (2010).
16. Chen, X. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell research 18, 997-1006, doi: 10.1038/cr.2008.282 (2008).
17. Creemers, E. E., Tijsen, A. J. & Pinto, Y. M. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circulation research 110, 483-495, doi: 10.1161/CIRCRESAHA.111.247452 (2012).
18. Moussay, E. et al. MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America 108, 6573-6578, doi: 10.1073/pnas.1019557108 (2011).
19. He, F. et al. Predictive value of circulating miR-328 and miR-134 for acute myocardial infarction. Molecular and cellular biochemistry 394, 137-144, doi: 10.1007/s11010-014-2089-0 (2014).
20. Szabo, D. R. et al. Analysis of circulating microRNAs in adrenocortical tumors. Laboratory investigation; a journal of technical methods and pathology 94, 331-339, doi: 10.1038/labinvest.2013.148 (2014).
21. Zhang, X. et al. Screening and identification of six serum microRNAs as novel potential combination biomarkers for pulmonary tuberculosis diagnosis. Plos one 8, e81076, doi: 10.1371/journal.pone.0081076 (2013).
22. Huang, X. et al. Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer. European urology 67, 33-41, doi: 10.1016/j.eururo.2014.07.035 (2015).
23. Tan, Y., Ge, G., Pan, T., Wen, D. & Gan, J. A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease. Plos one 9, e105192, doi: 10.1371/journal.pone.0105192 (2014).
24. Lopez, J. P. et al. miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment. Nature medicine 20, 764-768, doi: 10.1038/nm.3582 (2014).
25. Rouzier, R. et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clinical cancer research: an official journal of the American Association for Cancer Research 11, 5678-5685, doi: 10.1158/1078-0432.CCR-04-2421 (2005).
26. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747-752, doi: 10.1038/35021093 (2000).